ALS-linked proteostasis stress lowers effective GPX4 reserve in vulnerable motor neurons, allowing oxidized phospholipids to cross a ferroptotic death threshold. Restoring GPX4 activity or glutathione availability should rescue motor-neuron survival more strongly than generic antioxidants.
No AI visual card yet
Curated Mechanism Pathway
Curated pathway diagram from expert analysis
flowchart TD
A["ALS proteostasis stress"] --> B["GPX4 reserve depletion"]
A --> C["Glutathione depletion"]
B --> D["Oxidized phospholipid accumulation"]
C --> D
D --> E{"Ferroptotic threshold crossed?"}
E -->|" Yes "| F["Ferroptosis activation"]
F --> G["Motor neuron death"]
E -->|" No "| H["Motor neuron survival"]
B --> I["GPX4 activity restoration"]
C --> J["Glutathione supplementation"]
I --> K["Neuroprotection"]
J --> K
K -->|" Rescues "| G
style A fill:#ffd54f
style B fill:#4fc3f7
style C fill:#4fc3f7
style D fill:#4fc3f7
style E fill:#ef5350
style F fill:#ef5350
style G fill:#ef5350
style I fill:#81c784
style J fill:#81c784
style K fill:#81c784
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
3 citations0 with PMIDValidation: 70%2 supporting / 1 opposing
✓For(2)
No supporting evidence
No opposing evidence
(1)Against✗
HighMediumLow
HighMediumLow
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
3
MECH 3CLIN 0GENE 0EPID 0
Claim
Stance
Category
Source
Strength ↕
Year ↕
Quality ↕
PMIDs
Abstract
No claim
Supporting
MECH
Ferroptosis med…
-
2022
-
-
-
No claim
Supporting
MECH
Overexpression …
-
2021
-
-
-
No claim
Opposing
MECH
-
-
-
-
-
-
Legacy Card View — expandable citation cards
✓ Supporting Evidence
2
No claim
Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis · 2022
No claim
Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice · 2021
✗ Opposing Evidence
1
No claim
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-26 | View Analysis
🧬TheoristProposes novel mechanisms and generates creative hypotheses▼
Three mechanisms deserve priority: loss of GPX4 reserve in stressed motor neurons, ACSL4/LPCAT3-driven enrichment of oxidizable PUFA phospholipids, and genotype-specific iron mishandling in SOD1/TDP-43/FUS disease states. Each is testable with lipidomics plus ferroptosis-rescue controls.
🔍SkepticIdentifies weaknesses, alternative explanations, and methodological concerns▼
The key weakness is causal ordering. Lipid peroxidation appears in many dying neurons, so experiments must show that ferroptosis blockade rescues motor-neuron survival after controlling for apoptosis, necroptosis, mitochondrial collapse, and inflammatory toxicity.
🎯Domain ExpertAssesses practical feasibility, druggability, and clinical translation▼
Translation requires biomarkers before treatment trials: CSF/plasma 4-HNE, F2-isoprostanes, oxidized PE species, GPX4 activity, and iron MRI should stratify patients. Deferiprone-like strategies need careful anemia and mitochondrial safety monitoring.
⚖SynthesizerIntegrates perspectives and produces final ranked assessments▼
Ranked synthesis: prioritize GPX4 reserve failure, then PUFA-phospholipid substrate loading, then labile iron pool expansion. The program should demand orthogonal death-pathway exclusion and genotype-aware rescue studies.